by John S. James
Summary: Our new toll-free editorial and business number is 1-800-804-8845 — Monday through Friday 2 p.m. to 5 p.m. Eastern time (11 a.m. to 2 p.m. Pacific time), or leave a message. This number is for editorial and business calls; please do not list it as a hotline.
—————————————-
We are changing our toll-free editorial and business number to 1-800-804-8845. This number, effective now, will forward anywhere, so you can more easily reach a person during our new business hours, currently 2 p.m. to 5 p.m. Eastern time Monday through Friday (11 a.m. to 2 p.m. Pacific time). Voicemail messages at other times will be emailed to us immediately.
Please delete the old numbers (800-treat-1-2 or 800-873-2812, and the -3776 number) from all listings. We will have forwarding or a referral message there for the rest of 2007 at least, but due to spam calls the new number may not be announced on those lines. So make a note of it — or check on any page of this or any later issue of AIDS Treatment News.
Our toll-free number is not a hotline, as we are not set up to handle hotline calls. It is for editorial calls about what AIDS Treatment News has published (or should publish), or for business such as billing or change of address. See hotline information below.
—————————————-
Also see our AIDS Treatment News Daily Alerts, updated every day at www.aidsnews.org/now
Return to home page: www.aidsnews.org
Free subscription to AIDS Treatment News announcements online: send a blank email to subscribe@aidsnews.org — and reply to the email request from Yahoo to confirm your subscription. You will receive about five emails or fewer per month and can leave the list at any time. Or just visit www.aidsnews.org to read the articles — no subscription or registration required. [Note: subscriptions to AIDS Treatment News Daily Alerts are handled separately at www.aidsnews.org/now]
Copyright 2007 by John S. James. We prefer that you link to www.aidsnews.org or a specific article — no permission required. Otherwise permission is granted for nonprofit use. Please check with us (aidsnews@aidsnews.org) before copying articles more than a year old.